Tag:
Emtriva
Latest Headlines
Latest Headlines
Pharmasset science founder lands a fortune from $11B Gilead buyout
Emory University researcher and prolific biotech entrepreneur Raymond Schinazi will be $440 million richer once Gilead's ( $GILD ) $11 billion buyout of Pharmasset ( $VRUS ) goes through. That four
Gilead Sciences, J&J up the ante on new HIV drug combos
Gilead Sciences ( $GILD ) and Johnson & Johnson ( J&J ) are taking their close partnership on new HIV drug combos to the proverbial next level. About four months since their deal to mix Gilead's
Gilead first to jump into AIDS patent pool
Gilead Sciences ( $GILD ) has broken the ice on the AIDS drug patent pool. In a deal that will allow poor countries cheap access to its treatments, the company will share two of its leading HIV
HIV drugs may find preventive use
Should HIV drugs be used to prevent infection with the deadly virus? Some say yes. Given the fact that vaccine developers have to
